Skip to main content
Midas Edge

CNO Financial Group, Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

CNO$57.16+3.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 5. Other Information

Rule 10b5-1 Trading Arrangements

During the three months ended June 30, 2026, certain officers (as defined in Rule 16a-1(f) of the Exchange Act) (the "Section 16 officers") of the Company adopted separate Rule 10b5-1 trading arrangements (as defined in Item 408(a) of Regulation S-K) for the sale of the Company’s common stock. The following summarizes the material terms of such Rule 10b5-1 trading arrangements, which are intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act and the Company’s policies regarding transactions in Company securities:

Name and title of officerDate of trading arrangementDuration of trading arrangement (a)Aggregate shares of common stock to be sold pursuant to the trading arrangement (b)
Karen J. DeToroMay 11, 2026February 26, 202724,674
President, Worksite Division
Jeanne L. LinnenbringerMay 8, 2026February 26, 202714,539
Chief Operations Officer
Paul H. McDonoughJune 18, 2026August 23, 202732,407 (c)
Chief Financial Officer
Jeremy D. WilliamsMay 8, 2026March 15, 20278,782
Chief Actuary
Matthew J. ZimpferJune 4, 2026August 17, 202717,721
General Counsel

(a) Trading arrangement will terminate on the earlier of the date (i) stated in this column, (ii) on which the aggregate

number of shares has been sold, or (iii) on which the individual gives the designated agent notice to terminate.

(b) Aggregate shares to be sold will be subject to reduction of certain shares surrendered to satisfy required tax

withholding obligations upon future vesting events.

(c) Of these shares,18,600 are performance share grants of which the number of underlying shares to vest will depend upon achievement of certain financial metrics for the Company's 2024 - 2026 performance period.

During the three months ended June 30, 2026, other than the individuals included in the table above, none of the Company's directors and no other Section 16 officers adopted, terminated or modified a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.